PMC3469074_01
Abdominal mass biopsy showing mesothelioma (H&E, low power).
CRIM.ONCMED2012-619348.001.jpg
PMC3469074_01_CRIM.ONCMED2012-619348.001.jpg
fig1
D240, and negative for CEA and MOC31 (Figures 1, 2, 3, 4, and 5). Due to the extension of his disease, it was considered nonresectable.
Mesothelioma (H&E, high power).
CRIM.ONCMED2012-619348.002.jpg
PMC3469074_01_CRIM.ONCMED2012-619348.002.jpg
fig2
D240, and negative for CEA and MOC31 (Figures 1, 2, 3, 4, and 5). Due to the extension of his disease, it was considered nonresectable.
Immunohistochemistry showing calretinin-positive cells.
CRIM.ONCMED2012-619348.003.jpg
PMC3469074_01_CRIM.ONCMED2012-619348.003.jpg
fig3
D240, and negative for CEA and MOC31 (Figures 1, 2, 3, 4, and 5). Due to the extension of his disease, it was considered nonresectable.
Immunohistochemistry showing cytokeratin-positive cells.
CRIM.ONCMED2012-619348.004.jpg
PMC3469074_01_CRIM.ONCMED2012-619348.004.jpg
fig4
D240, and negative for CEA and MOC31 (Figures 1, 2, 3, 4, and 5). Due to the extension of his disease, it was considered nonresectable.
Immunohistochemistry showing D240-positive cells.
CRIM.ONCMED2012-619348.005.jpg
PMC3469074_01_CRIM.ONCMED2012-619348.005.jpg
fig5
D240, and negative for CEA and MOC31 (Figures 1, 2, 3, 4, and 5). Due to the extension of his disease, it was considered nonresectable.